Study on FOLFOX6 as First-line Therapy to Treat Recurrent or Metastatic Esophageal Cancer
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to explore whether FOLFOX6 as treatment could improve the time to
progression (TTP) and overall survival (OS) of the patient with recurrent or metastatic
esophagus.